Literature DB >> 23038404

Prevalence of cardiovascular events in patients with autosomal dominant polycystic kidney disease.

Imed Helal1, Berenice Reed, Pamela Mettler, Kim Mc Fann, Oleksandra Tkachenko, Xiang-Dong Yan, Robert W Schrier.   

Abstract

BACKGROUND: This study evaluates the prevalence of cardiovascular events in autosomal dominant polycystic kidney disease (ADPKD) patients.
METHODS: We distributed surveys to 1,439 subjects from our ADPKD research database. In total, 426 subjects completed and returned surveys; 7 of these were from children and were excluded from the study.
RESULTS: The patients who responded were female (63.2%), nonHispanic (88.1%) and white (93.6%). The mean age of the total group was 53.2 ± 13.7 years; 82.8% had a family history of ADPKD and 32.5% had reached end-stage renal disease (ESRD). With respect to cardiovascular risk factors, 86.6% were hypertensive with a mean age at diagnosis of 36.9 ± 12.9 years and hypertension was significantly more prevalent in males. In addition, 19.6% of the subjects were obese, 20.8% were smokers, 8.7% had diabetes, 45.7% had high cholesterol and 17.8% were sedentary. The most prevalent self-reported cardiovascular events were arrhythmias (25.9%), evidence of peripheral vascular disease (16.5%), heart valve problems (14.4%), cardiac enlargement (9.5%), stroke or cerebral bleeding (7.5%), myocardial infarction (6%) and brain aneurysm (5.0%). The most commonly used antihypertensive medications were renin-angiotensin inhibitors used by 75% of ADPKD patients. Older ADPKD patients and those at ESRD had a significantly higher incidence of cardiovascular events.
CONCLUSION: These findings support the high prevalence of cardiovascular risk factors and events in ADPKD patients which contribute to a greater mortality risk. Due to the prevalence of cardiovascular risk factors in the ADPKD population, early diagnosis and clinical intervention are recommended.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2012        PMID: 23038404      PMCID: PMC4527158          DOI: 10.1159/000343281

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN: 0250-8095            Impact factor:   3.754


  48 in total

1.  Screening for unruptured intracranial aneurysms in autosomal dominant polycystic kidney disease.

Authors:  D O Wiebers; V E Torres
Journal:  N Engl J Med       Date:  1992-09-24       Impact factor: 91.245

Review 2.  Cardiovascular mortality of patients with polycystic kidney disease on dialysis: is there a lesson to learn?

Authors:  E Ritz; M Zeier; P Schneider; E Jones
Journal:  Nephron       Date:  1994       Impact factor: 2.847

3.  Factors affecting the progression of renal disease in autosomal-dominant polycystic kidney disease.

Authors:  P A Gabow; A M Johnson; W D Kaehny; W J Kimberling; D C Lezotte; I T Duley; R H Jones
Journal:  Kidney Int       Date:  1992-05       Impact factor: 10.612

4.  Elevated blood pressure profile and left ventricular mass in children and young adults with autosomal dominant polycystic kidney disease.

Authors:  M Zeier; S Geberth; K G Schmidt; A Mandelbaum; E Ritz
Journal:  J Am Soc Nephrol       Date:  1993-02       Impact factor: 10.121

5.  Value of magnetic resonance angiography for the detection of intracranial aneurysms in autosomal dominant polycystic kidney disease.

Authors:  J Huston; V E Torres; P P Sulivan; K P Offord; D O Wiebers
Journal:  J Am Soc Nephrol       Date:  1993-06       Impact factor: 10.121

6.  Echocardiographic findings in autosomal dominant polycystic kidney disease.

Authors:  K F Hossack; C L Leddy; A M Johnson; R W Schrier; P A Gabow
Journal:  N Engl J Med       Date:  1988-10-06       Impact factor: 91.245

7.  Saccular intracranial aneurysms in autosomal dominant polycystic kidney disease.

Authors:  W I Schievink; V E Torres; D G Piepgras; D O Wiebers
Journal:  J Am Soc Nephrol       Date:  1992-07       Impact factor: 10.121

8.  Intracranial aneurysms in autosomal dominant polycystic kidney disease.

Authors:  A B Chapman; D Rubinstein; R Hughes; J C Stears; M P Earnest; A M Johnson; P A Gabow; W D Kaehny
Journal:  N Engl J Med       Date:  1992-09-24       Impact factor: 91.245

9.  Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension.

Authors:  M J Koren; R B Devereux; P N Casale; D D Savage; J H Laragh
Journal:  Ann Intern Med       Date:  1991-03-01       Impact factor: 25.391

10.  Occult intracranial aneurysms in polycystic kidney disease: screening with MR angiography.

Authors:  P M Ruggieri; N Poulos; T J Masaryk; J S Ross; N A Obuchowski; I A Awad; W E Braun; J Nally; J S Lewin; M T Modic
Journal:  Radiology       Date:  1994-04       Impact factor: 11.105

View more
  26 in total

1.  The relation of anthropometric measurements and insulin resistance in patients with polycystic kidney disease.

Authors:  Bennur Esen; Emel Sağlam Gokmen; Mahmut Kaya; Burak Ozkan; Ahmet Engin Atay
Journal:  J Transl Int Med       Date:  2016-09-23

2.  Deletion of cardiac polycystin 2/PC2 results in increased SR calcium release and blunted adrenergic reserve.

Authors:  Elisabeth DiNello; Elisa Bovo; Paula Thuo; Thomas G Martin; Jonathan A Kirk; Aleksey V Zima; Quan Cao; Ivana Y Kuo
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-09-18       Impact factor: 4.733

3.  Endothelial nitric oxide synthase gene expression is associated with hypertension in autosomal dominant polycystic kidney disease.

Authors:  Ismail Kocyigit; Serpil Taheri; Elif Funda Sener; Aydin Unal; Eray Eroglu; Fahir Öztürk; Kezban Korkmaz; Gokmen Zararsiz; Hakan Imamoglu; Murat Hayri Sipahioglu; Bulent Tokgoz; Oktay Oymak
Journal:  Cardiorenal Med       Date:  2014-12-10       Impact factor: 2.041

Review 4.  ADPKD: clinical issues before and after renal transplantation.

Authors:  Piergiorgio Messa; Carlo Maria Alfieri; Emanuele Montanari; Mariano Ferraresso; Roberta Cerutti
Journal:  J Nephrol       Date:  2016-10-20       Impact factor: 3.902

5.  Echocardiographic Findings and Genotypes in Autosomal Dominant Polycystic Kidney Disease.

Authors:  Ryohei Miyamoto; Akinari Sekine; Takuya Fujimaru; Tatsuya Suwabe; Hiroki Mizuno; Eiko Hasegawa; Masayuki Yamanouchi; Motoko Chiga; Takayasu Mori; Eisei Sohara; Shinichi Uchida; Naoki Sawa; Yoshifumi Ubara; Junichi Hoshino
Journal:  Kidney Dis (Basel)       Date:  2021-11-26

6.  Ketogenic dietary interventions in autosomal dominant polycystic kidney disease-a retrospective case series study: first insights into feasibility, safety and effects.

Authors:  Sebastian Strubl; Simon Oehm; Jacob A Torres; Franziska Grundmann; Jazmine Haratani; Morgan Decker; Sabrina Vuong; Amrit Kaur Bhandal; Nils Methot; Rhianna Haynie-Cion; Franziska Meyer; Florian Siedek; Uwe Korst; Roman-Ulrich Müller; Thomas Weimbs
Journal:  Clin Kidney J       Date:  2021-09-13

7.  Early cardiovascular manifestations in children and adolescents with autosomal dominant polycystic kidney disease: a single center study.

Authors:  Vasiliki Karava; Cherine Benzouid; Julien Hogan; Claire Dossier; André Pierre Denjean; Georges Deschênes
Journal:  Pediatr Nephrol       Date:  2018-05-17       Impact factor: 3.714

8.  Multiple cardiovascular manifestations in a patient with autosomal dominant polycystic kidney disease.

Authors:  Young Ran Kang; Jong-Hwa Ahn; Kye Hwan Kim; Young Min Choi; Jungwoo Choi; Jeong Rang Park
Journal:  J Cardiovasc Ultrasound       Date:  2014-09-29

9.  Progression of autosomal dominant kidney disease: measurement of the stage transitions of chronic kidney disease.

Authors:  Christopher M Blanchette; Caihua Liang; Deborah P Lubeck; Britt Newsome; Sandro Rossetti; Xiangmei Gu; Benjamin Gutierrez; Nancy D Lin
Journal:  Drugs Context       Date:  2015-04-17

10.  Renal replacement therapy in ADPKD patients: a 25-year survey based on the Catalan registry.

Authors:  Víctor Martínez; Jordi Comas; Emma Arcos; Joan Manel Díaz; Salomé Muray; Juan Cabezuelo; José Ballarín; Elisabet Ars; Roser Torra
Journal:  BMC Nephrol       Date:  2013-09-05       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.